Norstella Launches Atlas, an Agentic AI Platform Built on Biopharma’s Most Connected Data
New York – July 28, 2026: Norstella, the leading global provider of pharma intelligence solutions, today announced the launch of the Pipeline-to-Patient Productivity Index (P3i), a new annual benchmark measuring R&D productivity, market access, and commercial return across the top 25 global biopharma companies.
Norstella Launches Pipeline-to-Patient Productivity Index to Benchmark Biopharma Performance Across the Drug Development Lifecycle
New York – July 28, 2026: Norstella, the leading global provider of pharma intelligence solutions, today announced the launch of the Pipeline-to-Patient Productivity Index (P3i), a new annual benchmark measuring R&D productivity, market access, and commercial return across the top 25 global biopharma companies.
Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program
LONDON, June 25, 2026 – Evaluate, a Norstella company and the leading global provider of market insights for the pharmaceutical industry, today announced that Ask Ella has been named “Enterprise AI Search Solution of the Year” in the 9th annual AI Breakthrough Awards program.
Recursion Expands Strategic Partnership with Citeline to Advance its AI-Enabled ClinTech Platform
New York and Salt Lake City – Mar. 31, 2026 – Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation.
Fred Hassan Appointed Executive Chair of Norstella
New York, New York – Jan. 12, 2026 – Norstella, a leading global provider of pharma intelligence solutions, announced today that healthcare industry leader Fred Hassan has been appointed Executive Chair.
Norstella Appoints Dan Tempesta as Chief Financial Officer
New York, New York – Sept. 9, 2025 – Norstella, a leading global provider of pharma intelligence solutions, has appointed Dan Tempesta as its new Chief Financial Officer. This marks an exciting milestone in Norstella’s journey and underscores the company’s commitment to its next phase of growth.
Panalgo Revolutionizes Real-World Data with Launch of LinQ Notes and Ella AI
Boston, MA – May 14, 2025 – Panalgo, a Norstella company dedicated to revolutionizing healthcare analytics, today announced the launch of two game-changing solutions: LinQNotes and Ella AI. Together, these solutions mark a bold step forward in Panalgo’s mission to make insights more accessible, actionable, and immediate. Ella AI and LinQNotes combine the power of structured and unstructured data analysis to deliver a more complete view of the patient journey—from rapid cohort creation to rich clinical context.
Norstella Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
New York – March 18, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy.
Neelesh Sali Named Managing Director & Country Head of Norstella India
New York – February 5, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to announce the appointment of Neelesh Sali as Managing Director and Country Head for India. With over 30 years of leadership experience driving operational excellence and scaling global organizations, Neelesh brings a proven track record of transformative growth and innovation to Norstella’s mission of smoothing the path to life-saving treatments.
NorstellaLinQ Data Source Added to Atropos Evidence™ Network, Scoring in the Top Decile for Data Quality on Real World Fitness Score®
Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully integrated data asset combining real-world data (RWD) and proprietary intelligence from the most trusted brands in the industry, paving the way for breakthroughs in drug development and commercialization.
